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Abstract
Histopathology images; microscopy images of stained tissue biopsies con-
tain fundamental prognostic information that forms the foundation of patho-
logical analysis and diagnostic medicine. However, diagnostics from histopathol-
ogy images generally rely on a visual cognitive assessment of tissue slides
which implies an inherent element of interpretation and hence subjectivity.
Access to digitized histopathology images enabled the development of com-
putational systems aiming at reducing manual intervention and automating
parts of pathologists’ workflow. Specifically, applications of deep learning to
histopathology image analysis now offer opportunities for better quantitative
modeling of disease appearance and hence possibly improved prediction of
disease aggressiveness and patient outcome. However digitized histopathol-
ogy tissue slides are unique in a variety of ways and come with their own
set of computational challenges. In this survey, we summarize the different
challenges facing computational systems for digital pathology and provide
a review of state-of-the-art works that developed deep learning-based solu-
tions for the predictive modeling of histopathology images from a detection,
stain normalization, segmentation, and tissue classification perspective. We
then discuss the challenges facing the validation and integration of such deep
learning-based computational systems in clinical workflow and reflect on fu-
ture opportunities for histopathology derived image measurements and better
predictive modeling.
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Table 1: Nomenclature: list of used abbreviations and mathematical symbols.
Abbreviation Description
WSI Whole Slide Image
CAD Computer-aided diagnosis
H&E Hematoxylin and Eosin
IHC Immunohistochemistry
HPF High Power Field
IF Immuno Fluorescence
CD Color Deconvolution
SN Stain Normalization
LoG Laplacian of Gaussian
CNN Convolution Neural Network
FCN Fully Convolutional Neural Network
RNN Recurrent Neural Network
LSTM Long Short Term Memory
SAE Stacked Auto Encoder
SSAE Sparse Stacked Auto Encoder
VAE Variational Auto Encoder
GAN Generative Adversarial Network
cGAN Conditional GAN
F1 F1 Score
Acc Accuracy
P Precision
R Recall
N Total dataset size
X Input whole slide image
x Input patch
Y Ground truth whole slide image label
y Ground truth patch label
L(.) Loss function
fl(.) Neural network function at layer l
W Neural network parameters
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Chapter 1
Introduction
Histology is the microscopic inspection of plant or animal tissue. It is a critical
component in diagnostic medicine and a tool for studying the pathogenesis and
biology of processes such as cancer, cell duplication or embryogenesis.
The clinical management of many systemic diseases, including cancer, is informed
by histopathological evaluation of biopsy tissues, wherein thin sections of a biopsy
are processed to visualize tissue and cell morphologies for signs of disease. Digital
pathology incorporates the acquisition, management, sharing and interpretation of
pathology information; including slides and data, in a digital environment. Digital
slides are created when glass slides are captured, with a scanning device, to provide
a high-resolution digital image that can be viewed on a computer screen or mobile
device. Over the past few years, researchers have been starting to apply the tools
of deep learning to scanned digital slides (i.e., histopathology images or whole slide
images) in order to perform tasks such as primary clinical diagnosis, secondary
consultation, clinical outcome and analysis of abnormalities in tissues.
This first chapter gives a brief outline of the unique opportunities and challenges
for deep learning applications in digital pathology then summarizes the purpose,
scope and layout of this report.
1.1 Digitized Pathology and Deep Learning: Chal-
lenges and Opportunities
Over the last decade, the advent and subsequent proliferation of whole slide digi-
tal scanners has resulted in a substantial amount of clinical and research interest
in digital pathology; the process of digitization of tissue slides. Diagnosis from
histopathology slides has many advantages: 1) fast acquisition (5-10 min diagnosis),
2) not as costly as other tests such as molecular profiling, 3) can be performed in real
time or during surgery for guiding surgeons with frozen tissue sections, for instance,
and 4) essential for diagnosis, oncology and personalized treatment.
At the moment, a major limitation of the digital pathology slide is the unas-
sisted human interpretation currently used for analysis. To promote consistency
and objective inter-observer agreement, most pathologists are trained to follow sim-
ple algorithmic decision rules that sufficiently stratify patients into reproducible
groups based on tumor type and aggressiveness. For example, in the most common
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group of brain tumors known as diffuse gliomas, the pathologist first begins by ex-
amining nuclear morphology to decipher a cell of origin (e.g., astrocytoma vs. oligo-
dendroglioma). Once this first decision is established, the pathologist next assigns
a degree of malignancy based on the presence of mitotic activity, tumor necrosis,
and vascular proliferation [33]. Even with these simplified algorithms that focus
on binary and sufficiently different features, inter-observer discordance still persist,
even among sub-specialists [91]. This diagnostic uncertainty has promoted liberal
and widespread use of costly molecular testing to differentiate between seemingly
histologically indistinguishable lesions. Similarly, in efforts to maintain diagnos-
tic objectivity, other potential prognostic and therapeutic morphologic biomarkers,
such as foci of tumor-infiltrating lymphocytes and fibrotic tumor reaction, are often
omitted. Indeed, even in the molecular era, the unassisted physician still largely re-
lies on simple decision tree approaches that utilize only a small fraction of available
molecular or genomics knowledge. This simplified approach to analyze histopathol-
ogy is thus not fully leveraging the complex morphological information present for
optimal patient treatment and outcome.
Interobserver agreement low scores encourage the introduction of computer-aided
diagnostic (CAD) systems that can alleviate the need for human based decision rules
and introduce more robust and accessible quantification systems. Specifically, deep
neural networks have become the state-of-the-art machine learning based approach
for most computer vision and medical image analysis tasks [55]. However, adopting
deep models for digital pathology applications faces several challenges. Most of these
challenges are related to the multi-magnification, high dimensional (i.e. millions of
pixels) nature of histopathology slides and their acquisition.
1.2 Purpose and Scope of this Survey
In this report, we identified and reviewed 85 published works that form the state-
of-the-art in terms of image analysis and deep learning methods tailored primarily
for digital pathology images. Specifically, we discuss how while early attempts at
detection and segmentation of tissue biomarkers in digital pathology images were
rooted in traditional computer vision methods, there has been an evolution in the
approaches in order to address the specific challenges associated with image analysis
and classification of whole slide pathology images. Additionally, we discuss how
the state-of-the-art deep neural networks are designed for high dimensional multi-
magnification histopathology images as well as emerging research areas that are
not always related to automating clinical tasks but a byproduct of computerized
systems. We conclude the report with a discussion of some of the regulatory and
technical hurdles that need to be overcome prior to the wide-spread dissemination
and adoption of deep learning based solutions in clinical practice.
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The remainder of this report is organized as follows: First, we briefly introduce
the unique steps of the acquisition procedure of digital pathology slides. Then we re-
view the different existing applications of deep learning models for digital pathology
image analysis. We continue by giving a detailed overview of state-of-the-art deep
learning methods from the datasets and architectures used to the validation strate-
gies employed. Finally, we conclude with a summary and discussion and provide a
Table 5.2 categorizing the different works reviewed in the report.
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Chapter 2
Image Acquisition in Digital Pathol-
ogy
Whole slide images (WSI) are digital images derived from biological specimens.
Utilizing high-throughput, automated digital pathology scanners, it is possible to
digitize an entire glass-mounted tissue slide observed under bright-field or fluorescent
conditions, at a magnification comparable to a microscope. A major advantage of the
digitization of tissue slides is that it facilitates sharing microscopy images between
remote locations (i.e., telepathology) but also enables the integration of automated
image analysis tools into pathology workflows and assist experts in the interpretation
and quantification of biomarker expression within tissue sections [62].
While digitizing pathology slides offers many advantages, the digitization pro-
cedure comes with important challenges that can hinder the visual analysis and
computer-aided diagnosis of WSI. This chapter describes the step-by-step process
of digitizing glass-mounted tissue slides and the challenges that derive from this
procedure. Figure 2.1 summarizes these steps.
2.1 Tissue Preparation
The process of preparing tissue slides for digital pathology analysis begins with a
physician requesting a histology confirmation after assessing a patient with a phys-
ical exam and/or radiology and laboratory results. The clinical histology process
starts by collecting enough good-quality tissue for a diagnosis. There are several ap-
proaches for tissue collection, including fine-needle aspiration, needle biopsy, excision
biopsy or excision of a lesion in its entirety. Each of these collection techniques can
alter the visual analysis of tissues and influence the final diagnosis accuracy. In fact,
larger biopsies preserve more cellular context and allow the pathologist to examine
multiple slides from different areas of the sampled tissue. Hence, the diagnosis is
generally more reliable and accurate when determined from tissues collected with
entire lesion excision as opposed to fine-needle aspiration. The sensitivity and speci-
ficity of computerized systems to the collection method are not clearly defined yet
but one can assume that larger biopsy specimens would allow for a better diagnosis
as they would result in more information (more images) but also more preserved
context. After biopsy, a pathologist analyses the tissue at a macroscopic scale, mea-
suring it and trimming it to fit into a tissue cassette container of size 10 × 10 × 3
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(a) Tissue Biopsy Collection (b) Tissue Cassettes Preparation (c) Fixation & Paraffin Embedding
(d) Sectioning (e) Staining (f) Digitization
Figure 2.1: Steps involved in the preparation of digital pathology images. Images
are borrowed from [62].
mm for the subsequent processing steps.
At this stage tissues are transparent, soft and thick and will undergo series of
steps allowing for their microscopy visual assessment. First, the collected tissue is
immersed into a fixative solution that is used to stop cells from breaking down and
tissues to be altered by microorganisms growth. After fixation, most tissues are
embedded in a hardening material (i.e., paraffin waxes) to facilitate their sectioning
(i.e., cutting) using a microtome. Certain tissues will require quick analysis and
are frozen and sectioned in a cryostat (a microtome inside a freezer). Fixation
and sectioning are critical steps in the preparation of histopathology slides as they
prevent autolysis (i.e., cellular self-destruction by enzymes), allow the tissue to be
kept close to its living state without loss of arrangement, and minimize changes in
shape or volume often caused by subsequent steps.
Once fixed and sectioned, tissue slices are still nearly invisible under a microscope
as biological tissues are transparent. Therefore, another important step in the tissue
preparation is tissue staining, which is the process of using dyes (generally chemical
agents or antibody agents in the case of immunohistochemical staining) that have
affinity for certain cell and extra-cellular components in order to create contrast.
The chemical properties of these dyes produce the visual appearance that is seen
under the microscope. In both diagnostic and research histopathology, the gold
standard tissue sections are stained with hematoxylin and eosin (H&E) where the
cell nuclei are stained in blue by the hematoxylin which stains nucleic acids while
cell cytoplasm is stained in pink/red by the eosin which stains proteins [20]. Finally,
8
after staining, a coverslip (i.e., small glass sheet) is placed over the tissue mounted
on the glass slide. This step creates an even thickness for viewing the tissue under
a microscope and prevents the microscope lens from touching the tissue.
While some parts of the tissue preparation procedure can be automated in certain
pathology centers (e.g., tissue fixation and sectioning can be done automatically with
specific laboratory workstations), tissue handling involves manual intervention and
introduces recognizable and well-documented artefacts in the case of paraffin fixed
and H&E stained tissue sections but less identifiable artefacts for other dyes. On
average, tissue preparation takes 9 to 12 hours [55]. After preparation, tissues can
be digitized.
2.2 Tissue Slide Digitization
Whole slide scanners are optical microscopes under robotic and computer control.
These microscopes are mounted with highly specialized cameras containing advanced
optical sensors that offer spatial resolutions of approximately 0.23-0.25 µ/pixel using
the 40x microscope objective [14]. The essential components of a whole slide scanner,
generally include the following: 1) a microscope with lens objectives, 2) light source
(bright field and/or fluorescent), 3) robotics to load and move tissue slides around,
4) one or more digital cameras for capturing images, 5) a computer, and 6) software
to manipulate, manage, and view the digitized slides.
Most whole slide scanners use a tiling or a line-scanning system to produce a WSI.
Tiling consists of acquiring multiple individual high-resolution images as tiles while
line-scanning creates linear scans of tissue areas. Both systems require stitching
and smoothing the tiles or line scans together to create a single digital image of the
histologic section.
An important distinction between digital pathology and light microscopy resides
in the concepts of magnification and resolution. In digital pathology, these concepts
must be considered in the context of how images are acquired and displayed. In
fact, magnification in light microscopy is determined by multiplying the power of
the objective (4x, 10x, 20x or 40x) by the power of the eyepiece (generally 10x). This
concept is not applicable in whole slide imaging as images are viewed on variably
sized screens that can further amplify or shrink the original magnification. Hence, in
digital pathology, for a whole slide image, the resolution is defined by the objective
used to scan the slide (usually referred to as the WSI magnification) and the imaging
sensor and is measured in micrometers per pixel.
Once digitized, histopathology tissue sections are stored as WSIs which are dig-
ital files with varying sizes. The size of the file depends on the scanning objective
and tissue size but commonly ranges from 200 MB to 10GB [98]. In the con-
text of health-care facilities, WSI files are significantly larger than digital image
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files routinely used in other clinical specialties such as radiology [35]. Therefore,
compression-decompression methods, both lossy (e.g., JPEG2000) and loss-less (e.g.,
TIFF) types, are employed to store WSI. Currently, there is no standard file format
for digital pathology images [98], although many vendors use the SVS format which
stores a WSI as a multi-layered pyramid of thousands of image files with conserved
filed of view and tile size spanning multiple folders. The pyramid representation
enable the optimized real-time viewing of a WSI across multiple resolutions. Al-
though, the JPEG2000 compressed format is being used by some vendors there is
an interest in migrating to the DICOM format as used in digital radiography [98].
2.3 Artefacts
In pathology, artefacts are the result of the alteration of a tissue from its living state
but in digital pathology, artefacts also include alterations of the rendered tissue
image.
The preparation of tissue slides and their digitization inevitably results in arte-
facts of various types that can compromise the image analysis and diagnosis. In
fact, tissue appearance can be altered by the fixation, the specimen orientation in
the block, the sectioning and the staining or immunolabelling steps which heavily
dependent on human skills or, if automated, on human monitoring, machine main-
tenance and solution preparation [70]. Differences in protocols between pathology
labs can greatly alter the appearance of even biologically similar tissue samples.
Moreover, the digitization step can also introduce additional artefacts. In fact, de-
pending on the digital scanner, the quality and resolution of the digitized tissue slide
can vary significantly.
A challenge in digital pathology is in identifying these artefacts and not con-
fusing them with normal tissue components or pathological changes. In practice,
pathologists learn to spot artefacts and depending on the extent of the damage on
tissues, some sections often have to be manually discarded. Automatic systems can
easily be sensitive to image and tissue artefacts which can cause the automatic im-
age analysis systems to fail. For this reason, different pre-processing methods are
generally used and most automatic systems have to account for inter and intra-slide
variability. While designing automatic WSI analysis systems that are robust to com-
mon artefacts observed in digital pathology is still an open problem, feature learning
via deep learning models enabled great progress in this direction. We discuss this
further in the next chapter.
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Chapter 3
Deep Learning Applications in Dig-
ital Pathology
Recent applications of deep learning models in various fields resulted in redefining
the state-of-the-art results achieved by earlier machine learning techniques. In digital
pathology, deep neural networks, when appropriately trained, have proven capable
of yielding diagnostic interpretations with accuracy similar to clinical experts [18].
Prior to the success of deep learning models, traditional machine learning mod-
els already proved to be useful in digital pathology. In fact, unlike the simplified
algorithms pathologists are trained to use, machine learning models enable learn-
ing more complex decision functions. However, these conventional machine learning
techniques usually do not directly deal with raw data but heavily rely on the data
representations (i.e., hand-crafted features such as color, texture or shape), which
require considerable domain expertise and sophisticated engineering. Many works
have been proposed with hand-designed features that are often task specific, thus,
do not generalize well across tissues and sites. Deep learning models, by leveraging
unsupervised or supervised feature learning, do not need heavy specialized applica-
tions, hence their quick success in digital pathology. In this chapter, we discuss the
different applications of deep learning models for a variety of clinical and non-clinical
tasks in digital pathology.
3.1 Computer-aided Diagnosis: Automating Clin-
ical Tasks
A number of image analysis tasks in digital pathology involve the quantification
and highlight of morphological features (e.g., cell or mitotic count, nuclei grading,
epithelial glands morphology). These tasks invariably require the identification (i.e.,
localization) of histologic primitives (e.g., cell, nuclei, mitosis, epithelium, cellular
membranes, etc.). The presence, extent, size and shape or other morphological ap-
pearance of these structures are indicators of the presence or severity of disease.
For instance, the size of epithelial glands in prostate cancer tend to reduce with
higher Gleason patterns. Another motivation for detecting and segmenting histo-
logic primitives arises from the need for counting of objects, generally cells or nuclei.
An example application is the Bloom Richardson grading system which is the most
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commonly used system for diagnosing invasive breast cancers and comprises three
main components: tubule formation, nuclear pleomorphism, and mitotic count. Mi-
totic count, which refers to the number of dividing cells (i.e., mitoses) visible in H&E
tissue slides, is widely acknowledged as a good predictor of tumor aggressiveness. In
practice, pathologists define mitotic count as the number of mitotic nuclei identified
visually in a fixed number of high power fields (HPFs, 400x magnification). Most
of these tasks are time-consuming for the human-eye and can be highly sensitive to
the level of expertise as well as the subjectivity of pathologists.
The majority of deep learning models proposed for digital pathology use su-
pervised learning in an attempt to automate the different parts of clinical experts’
visual analysis tasks. Identifying histologic primitives is one area of applications for
deep learning models. Another area is in the predictive modelling of outcome (i.e.,
cancer detection and classification, survival analysis) from WSIs which is the ulti-
mate goal of the visual analysis of tissue slides. Both of these areas of application
are motivated by the need for faster, more reliable and objective diagnostics and
improved patients outcome.
3.2 Non-clinical Tasks
Another category of applications that leverage deep learning models is the result of
computer-aided diagnosis itself. In fact, automatic systems generally require han-
dling dataset-related challenges that are not necessarily critical to pathologists and
are not directly involved in clinical tasks. Among such challenges, data harmoniza-
tion, specifically stain normalization is an important factor that was shown critical
in the development of computerized systems. While pathologists are less sensitive
to tissue variability induced by staining inconsistencies, automatic systems often fail
at generalizing to unseen datasets acquired with different staining protocols and can
be highly sensitive to staining variations across tissue slides. Recently, deep models
were proposed for staining normalization but also domain adaptation to handle such
challenges.
Another application concerns the generation of synthetic images via means of
digital staining (transferring stains across images), virtual staining (automatically
staining unstained tissues) or generative modelling (creating new images with re-
alistic textures and stains). There are different applications for these techniques
that we discuss in the remainder of this report. One direct application of genera-
tive learning is data augmentation as a way to overcome the scarcity of available
annotated datasets.
Finally, a recent and important application of deep models to digital pathol-
ogy concerns the design of interpretable computational systems. Interpretability is
generally a desirable property for most computer-aided diagnostic systems as it fa-
12
cilitates clinical integration. However, existing systems are not generally optimized
or designed for promoting interpretability of their outputs and underlying decision
rules. Recently, there have been more attempts at designing interpretable deep
models.
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Chapter 4
Deep Learning for Analyzing Digi-
tal Pathology Images
A wide variety of deep learning models have been proposed for analyzing digitized
tissue slides. Given the unique characteristics of WSIs many approaches present
ways to process these high dimensional images and leverage their special multi-
magnification nature. In this chapter, we discuss strategies to handle data scarcity
and class imbalance. Then, we present the most commonly employed neural network
architectures and describe the variety of deep learning systems, training strategies
and validation procedures that have been proposed for use on WSIs.
4.1 Digital Slide Representation and Datasets
Table 5.1 shows the different public datasets used in the studies we surveyed as well
as their corresponding size. In the works we reviewed the datasets used covered
a range of approximately 6 to 600 WSIs. While these are relatively small dataset
sizes compared to what is usually necessary for training deep learning models (e.g.,
thousands or millions of images), a unique particularity of WSIs is their very large
dimensions. As describe in section 2.2, WSIs contain millions of pixels which can be
leveraged efficiently to increase dataset sizes. Hence, all the works we surveyed in
Table 5.2 used a variant of patch-based techniques to augment the dataset size and
train deep learning models. For instance, for the task of detecting nuclei in tissue
slides, the datasets created from sampled patches centered at annotated nuclei can
contain thousands of positive instances from only dozens of available annotated
WSIs. Figure 4.1 shows the sizes in terms of WSIs and their total corresponding
annotated patches of the datasets used in different studies grouped per publication
year.
In practice, representing WSIs with patches is unavoidable. In fact, with current
state-of-the-art computing resources, it is impossible to process a WSI in its entirety
without extensively down-sampling the image which would result in loosing most of
the discriminative details and morphological features of the underlying tissues.
Although patch-based representations are unavoidable, they do come with im-
portant shortcomings. First, patch-based representations imply the loss of global
context captured within the multi-magnification levels of the tissue slide. In fact, tis-
sues’ structural organization is generally characterized by the different arrangements
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of cells and can only be observed at the lowest magnification levels (e.g., 20x or 10x)
or with very large scale patches. Different works attempt to encode context when
training deep models by using a pyramid representation in which input patches are
extracted at different magnification levels (often 20x and 40x) and processed with
multi-scale [12] or cascaded [19] deep network architectures.
The second problem often faced when using patch-based representations is class
imbalance. In fact, most applications involve datasets with very limited annotated
positive samples. For instance, in the task of mitotic detection, only a few nuclei are
generally labelled as mitotic, and the ratio of mitotic to non-mitotic nuclei can be
up to 1 to 1000 which can arguable be defined as a highly imbalanced dataset. Class
imbalance problems can be addressed by designing different patch sampling strate-
gies that maximize the ratio of positives to negatives. One common approach is
to densely sample positive patches and perform additional data augmentation with
affine and elastic deformations on positive patches only. More sophisticated ap-
proaches involve crowdsourcing[12] annotations, employing boosting techniques [27]
or relying on active learning [108].
For some tasks such as cancer classification, it can be difficult to collect patch
level annotations. In fact, most available dataset for cancer diagnosis are labelled
at the slide-level only (i.e., an entire WSI is labelled as cancerous or not but the
area of cancer is unknown). In these cases, it can be difficult to identify positive
from negative patches. Most works treat patches as independent instances and
extrapolate the slide-level label to all sampled patches from a given WSI. While this
approach can be efficient, it is fundamentally flawed and results in high false positive
patch predictions. A more accurate approach involves formulating classification and
segmentation tasks with slide-level annotations only as weakly labelled problems and
using machine learning frameworks such as multiple instance learning [46] to train
the deep learning models. Other strategies involve designing different aggregation
techniques to infer a slide-level prediction from all processed patches at inference
time. In this case, a trained model is applied on densely sampled patches from
a test WSI in a sliding window fashion and a slide-level prediction score map is
obtained. The most successful aggregation strategies involve training secondary
machine learning models (e.g., random forest) [18] as classifiers on hand-crafted
features (e.g., detected tumor size) extracted from the prediction score map obtained
from the patch-level deep model.
Finally, a commonly used strategy for overcoming small dataset sizes (despite
the large number of patches that can be extracted from a WSI) is to rely on pre-
trained deep learning models. In such case, models are first trained on very large
datasets from other domains (e.g., natural scene images) and fine-tuned on the
smaller available digital pathology datasets. For instance, it has been shown that
convolutional neural network (CNN) architectures trained on natural scene images
15
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Figure 4.1: Number of studies found per year categorized based on the type of task
they address (left) and the average size of the dataset they use (right). The number
of instances (#instances) correspond to the average number of annotated instances
available.
can generalize relatively well (even without fine-tuning) to a variety of digital pathol-
ogy tasks [18, 24, 61, 94, 69].
4.2 Deep Learning Architectures
The majority of deep learning models used in digital pathology are of type feed
forward or recurrent neural networks. Neural networks are commonly associated
with acyclic graphical models that describe a composition of many different functions
f approximating some unknown function f ∗. The goal of a neural network is to
define a mapping f(X,W) of an input X and learn the parameters W that result
in the best function approximation.
4.2.1 Convolutional Neural Networks
In digital pathology, CNNs are the most commonly used type of feed forward neural
networks. A CNN is a composition of a sequence of L layers (i.e., functions) that
maps an input image X to an output vector Y (e.g., a scalar or output vector) such
that:
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Y = f(X; w1,w2, . . . ,wL) (4.1)
= fL(aL−1; wL) ◦ fL−1(aL−2; wL−1) ◦ . . . ◦ f2(a1; w2) ◦ f1(X; w1) (4.2)
where W = {w1,w2, . . . ,wL} are the trainable parameters (weights and biases) at
different layers, {a1, a2, . . . , aL} represent the intermediate outputs at each layer
that form the networks’ features or internal activations. Conventionally, the succes-
sive layers of a CNN model are defined to perform one of the following operations:
i) 2D or 3D convolutions with trainable filter banks, ii) spatial pooling (e.g., average
or max pooling), iii) non-linear activations (e.g., rectified linear units, hyperbolic
tangent, sigmoid). Generally, the final layer of a CNN is represented as a fully con-
nected or dense layer that maps the penultimate output activations to a distribution
over categories P (Y |X;W) through a softmax function.
Among the works we surveyed in Table 5.2, the majority used CNN architec-
tures with relatively shallow architectures (i.e., 2 to 8 layers) when it comes to tasks
related to the analysis of histologic primitives (e.g., nuclei and cell localization, cell
classification). For instance, many works [36, 41, 69, 61] adopted LeNet [54] and
AlexNet [52] architectures with minor modifications to the penultimate layer output
size. Both of these networks are relatively shallow, consisting of two and five convo-
lutional layers, respectively and employed convolutional kernels with large receptive
fields in early layers and smaller kernels closer to the output. The main distinc-
tion of the AlexNet architecture is the use of rectified linear units instead of the
hyperbolic tangent as activation function. In contrast, most prediction models we
surveyed (e.g., cancer prediction and grading) rely on deeper network architectures
(i.e., 8 to 150 layers) [15, 58, 17, 94]. Generally, these architectures are adapted
from the VGG-16 [81], Inception [89] and ResNet [42] models which are all built
on small fixed-size kernels in each layer. These CNN architectures introduced novel
building blocks that were shown to improve training efficiency and reduce the total
amount of trainable parameters. Specifically, the Inception model consists of incep-
tion blocks where instead of having a single convolution layer applied to a given
input, the model uses multiple parallel operations (i.e., convolutions with varying
kernel sizes and pooling) applied to the same input. This strategy was shown to
act as a multi-level feature extraction scheme. In the ResNet architecture, residual
blocks are introduced in order to train very deep models (i.e., 150 layers) effec-
tively. Instead of learning a function, ResNet blocks only learn the residual and are
preconditioned towards learning mappings that are close to the identity function.
Finally, other works that did not use the above mentioned state-of-the-art archi-
tectures [29, 56, 30, 109] designed custom CNN models where the building blocks
are typically convolutions with varying kernel sizes depending on the dataset and
task, max pooling layers, rectified linear units as activations and fully connected
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layers that act as final classifier. An example of a common custom architecture
is the multi-scale CNN used for mitosis [12] and cell [88] detection. Multi-scale
architectures were proposed to incorporate larger context when using patch-based
representations of WSIs. A multi-scale CNN is composed of multiple parallel train-
able CNN architectures where each network includes a filter bank layer, non-linearity
functions and pooling operations and is trained on similar size patches extracted at
increasing input image scales. The output predictions obtained for all patches are
aggregated using an additional fully connected layer or using a simple geometric
average over all prediction scores to predict a single categorical output.
Another application of CNNs in digital pathology is as pixel-level classifiers in
segmentation tasks. To predict a class label for each pixel in an input image, a
common approach is to use a variant of a CNN named fully convolutional network
(FCN) [59]. The particularity of FCNs is that they can receive inputs of arbitrary
size and produce correspondingly-sized outputs by removing all fully connected lay-
ers and introducing upsampling layers to supplement the usual contracting CNN
network composed of stacked convolution, non-linearities and pooling (or downsam-
pling) layers. There are different variants of FCN architectures but the most popular
model used in digital pathology is the UNet [77] which uses VGG-16 as a contracting
network and combines it with its symmetric counterpart where all pooling layers are
replaced by upsampling operations to increase the resolution of the output and form
a u-shaped architecture. Skip connections are used to propagate information across
the network and facilitate training.
Whether they are used for classification, detection or segmentation, the parame-
tersW of feed forward neural networks (i.e., CNNs and their variants) are generally
trained in a supervised setting by optimizing a cost function. Given a set of N
annotated training instances {(X(i), Y (i))}, the parameters W can be estimated by
solving the following optimization problem:
min
W
N∑
i=1
L(P (Y (i)|X(i);W), Y (i)) +R(W), (4.3)
where L is a defined cost function and R is a regularization term over the train-
able parameters W . In most cases, weight decay is used as regularization and the
cost function is defined as the cross-entropy loss between the training data and the
model’s predictions:
L = − log
[
P (Y (i)|X(i);W)
]
. (4.4)
Common variants of the cross entropy loss in digital pathology involve adding a
weighting coefficient to handle class imbalance [100, 77, 83] or introducing additional
auxiliary terms [24] in the loss defined in eq.(4.4).
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Most deep models are optimized following eq.(4.3) in an end-to-end fashion using
stochastic gradient descent. In order to compute the gradients of the cost function
(eq.(4.4)) with respect to the network’s parameters, the backpropagation algorithm
is used to allow the information from the cost function to flow backward in a recursive
fashion.
4.2.2 Recurrent Neural Networks
Another category of neural networks often used in digital pathology are the recurrent
neural networks (RNNs) which are generally used to model sequential data where
the input and output (as in feed forward neural networks) can be of varying length.
In its simplest form, the particularity of an RNN is in the capacity to maintain a
latent or hidden state h at a given time t that is the output of a non-linear mapping
from its input Xt and given the previous state ht−1:
ht = f(ht−1,Xt;W), (4.5)
whereW are the trainable parameters and f is the non-linear mapping function that
is repeatedly applied to all input elements of the sequence X. For classification, one
or more fully connected layers are typically added followed by a softmax to map the
sequence to a posterior over the classes.
The training procedure for a RNN is similar to the one described above in eq.(4.3)
with the difference being that the total cost function for a given sequence X paired
with a sequence Y is simply the sum of the costs over all time steps (i.e., backprop-
agation through time).
Different variants of RNNs have been proposed. In digital pathology, the most
commonly used recurrent models are gated RNNs and long short term memory
(LSTM) networks that use additional gates (i.e., trainable non linear functions)
to accumulate and forget information over a long duration of time. LSTMs, as
opposed to gated RNN, incorporate gated self loops that are conditioned on the
current state and context. These self loops are primarily introduced to facilitate
training by modelling long-term dependencies and avoiding the gradients to vanish
through the successive time steps.
In the works we reviewed, RNNs and LSTMs have been primarily used for seg-
mentation tasks. In these applications, 2D WSIs are modelled as a sequence of
patches and dependencies between local patches are modelled using the recurrent
architectures. In order to model dependencies in both axis of the image (i.e., rows
and columns), most works use 2D versions of the recurrent networks. For instance,
Xie et al. [102] proposed a 2D spatial RNN to segment muscle perimysium in dig-
ital pathology images where each input image is partitioned into non overlapping
patches. In order to process an input image, the image patches are sorted in an
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acyclic sequence. Sub-hidden states are introduced and defined as a weighted combi-
nation of inputs from the 4-connected adjacent patches (left, right, top and bottom)
within rows and columns of a grid representing the organization of all patches in the
image. Similarly, 2D LSTMs can be used [10] to capture contextual information by
processing WSIs as a 2D sequence of non-overlapping neighbouring patches. The
input to the 2D LSTM model is represented as a sequence of two multi-dimensional
vectors (e.g., feature vectors obtained with a CNN). Each 2D LSTM unit is pair-
wise connected to its 4-connected neighbors and is composed of twice the number
of gates as exist in 1D LSTM units (i.e., input, output, forget and cell memory
gate) to process inputs from neighbouring patches along the columns and rows of
the original WSI.
Generally, recurrent models are integrated within CNN models to obtain fea-
ture representations of the input images and do not operate directly on raw input
images. In digital pathology, most existing recurrent networks are trained with
backpropagation and optimized with the cross entropy loss.
4.2.3 Unsupervised Models
A few works used unsupervised models to process digital pathology images. From
the works we reviewed, the majority used auto encoders (or a variant) and generative
adversarial networks in an unsupervised setting.
Auto encoders (AEs) are feed forward neural networks that are formed of fully
connected or convolutional layers with non linear functions used to compute each
layer’s activations. Most existing architectures follow the same design choices as the
ones used in CNNs. Generally, AEs are composed of a contracting path that reduces
the dimensionality of the input to a coarse latent representation and that is followed
by an upsampling path that recovers the input. Thus, AEs are trained to reconstruct
an input X on the output layer Xˆ through one or multiple hidden layers h. As AEs
are used to reconstruct inputs, they are generally trained with the mean squared
error which penalizes the reconstructed input Xˆ for being dissimilar from the input
X. A sparse autoencoder (SAE) is simply an AE whose training criterion involves
a sparsity penalty on the latent representation h, in addition to the reconstruction
error. Stacked Sparse auto encoders (SSAE) are formed by stacking multiple auto
encoder layers on top of each other and forming deeper networks.
In digital pathology, SSAE were used to obtain feature representations while
leveraging datasets in an unsupervised setting (i.e., without requiring annotations).
This feature learning strategy was shown successful on a variety of applications such
as cancer identification [31, 66] and nuclei detection [105].
Recently, another variant of AEs named variational auto encoders (VAE) was
employed to generate grayscale histopathology images [90]. VAEs are probabilistic
models used as generative models which aim at learning a probability distribution
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over a given training dataset. To do so, VAEs are trained to maximize the variational
lower bound on the log-likelihood of the data. These models are in essence different
from general AEs but they do follow the same architectural design with a contracting
path (the encoder) and upsampling path (the decoder). So far, there have been only
rare applications of VAEs to digital pathology images.
Another form of generative models that was shown useful in digital pathology
are the generative adversarial networks (GAN) [39]. The goal is to learn a generator
distribution PG(X) that matches the real data distribution Pd(X). GANs consist
of optimizing a minimax game between a generator G and discriminator network
D. Both of these networks are generally designed as CNNs. G generates samples
from the generator distribution PG(X) by transforming a noise variable z ∼ Pn(z)
into a sample G(z). D aims at distinguishing samples from the true data distri-
bution Pd(X) from generated samples G(z). The optimization involves finding the
parameters of both networks G and D using the following expression:
min
G
max
D
V (D,G) = Ex∼Pd [ logD(X)] + Ez∼Pn [ log(1−D(G(z)))] (4.6)
Different variants of GANs have been used in digital pathology for tasks such as
data augmentation, data harmonization, domain adaptation and staining normal-
ization [80, 44, 16, 65]. We discuss these works further in section 4.5.1.
4.3 Detection and Analysis of Histologic Primi-
tives
As mentioned previously, a critical prerequisite in the diagnosis of tissue sections
is the analysis of histologic primitives such as cells, nuclei, lymphocytes, mitotic
figures, etc. The detection of these important tissue components provides support
for various quantitative analysis tasks including cell and nuclei morphology, such as
size, shape, and texture which are biomarkers of abnormalities.
There exist many challenges in the detection of histologic primitives in digital
pathology. First, as mentioned in section 2.3, the appearance of tissue slides can
exhibit background clutter introduced during image acquisition but there exist also
significant variations on nuclei and cell sizes, shapes and intracellular intensity het-
erogeneity. Finally, cells and nuclei are often clustered into clumps and may overlap
partially with one another. Challenges related to anatomical variations and arte-
facts make the task of detecting cell and nuclei particularly suited for deep learning
models that can potentially learn robust feature representations. In this section
we describe different deep learning models proposed for the detection of histologic
primitives and specifically present supervised techniques with classification, regres-
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sion and segmentation deep neural networks as well as unsupervised techniques that
leverage deep auto encoders.
4.3.1 Classification Models
Many detection problems (i.e. nuclei, cell, mitosis detection) can be formulated
as a pixel or patch-wise classification task and characterized by the appearance of
objects to be detected. A common strategy for nuclei or cell detection is to train
a CNN classifier as a pixel classifier [48, 57, 68, 106] where the network is trained
in a supervised setting using patches centered around the object of interest. The
trained CNN model is often a two-class classifier and can be applied in a sliding
window fashion on WSIs to detect all histologic components of interest and output
a probability map, where each pixel value indicates the probability of one pixel
being at the center of an object. Therefore, the target objects can be located,
in principle, by seeking local maximum in the generated probability map. This
is generally followed by non-maxima suppression to improve the detection results.
The advantage of using a deep learning model in this case is mainly in leveraging
the learned feature representation that, if the training set allows, can be robust to
variations such as rotation, staining appearance, etc. This approach is evidently
more accurate than previous state-of-the-art hand-crafted features even when using
relatively small architectures such as shown by a variety of works that adopted
LeNet-5 [54] the 5-layer CNN model [75, 97] or proposed 3-layer CNN classifiers to
detect cells and nuclei [48, 49].
One important limitation of such pixel-wise classification approach lies in their
high computational costs. In practice, sliding window CNNs do not scale well to
the million pixel WSIs. To overcome this problem, different strategies have been
explored. Wang et al. [97] proposed to reduce redundant computations of neighbour-
ing patches by introducing k-sparse convolution kernels, pooling and fully connected
layers that are created by inserting zero rows and columns into the original kernels
to enlarge the kernel size hence enabling the network to be trained with larger in-
put tiles. The model is trained on 40 × 40 patches and tested on 551 × 551 tiles,
hence speeding up the total computation time at test time. In an extension to this
work [97], the authors also showed how distributed GPU systems could speed up the
total training time [94]. Xu et al. showed the applicability of k-sparse kernels to cell
detection on lung cancer images [106]. Giusti et al. [37] achieved a three order mag-
nitude speedup compared to standard sliding window by performing convolutions
with larger strides.
Another strategy proposed to improve CNN classifiers for detection tasks consists
of utilizing domain knowledge about the object to be detected and leveraging the
properties of the H&E staining. In fact, when detecting nuclei or mitotic figures,
many works [96, 76, 75, 49] observed that leveraging the hematoxylin channel which
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highlights nuclei in blue/dark purple would give a good estimate of the potential
nuclei centers and hence can be leveraged to generate relevant candidate proposals
to use along with the CNN for training. Often the hematoxylin image is filtered
out by computing the laplacian of Gaussian (LoG) which allows to detect blob
like structures then patches are extracted at those areas of detected nuclei to form
candidate proposals [75]. The LoG filter response can also be used to improve color
decomposition when separating the hematoxylin and eosin channels [49] which was
shown to improve nuclei detection. Chen et al. [23] proposed to use a FCN to first
quickly retrieve mitosis candidates and output a score map indicating the probability
of mitosis candidates. The FCN is followed by a CNN classifier in a cascaded
fashion where the CNN receives the retrieved candidates for further classification
into mitotic vs non mitotic nuclei. Both networks share convolutional layers and only
the last fully connected layers differ resulting in two different outputs. The model
is trained with a softmax classification loss and an L2 regularization term. Along
the line of works proposing candidate proposals to use prior to detection; Akram
et al. [11] propose a two-branch CNN where one branch regresses on bounding box
coordinates and the second predicts a classification score describing how likely the
detected box is to include a cell. The generated candidate proposals are then used
for training further training a cell classification CNN.
Pixel-wise classification can be easily extended to multi-class organ detection
using a softmax loss when training the CNN model. Such multi-class CNN can
still be trained with randomly sampled patches and applied on densely sampled
patches at test time. A similar strategy was used by Cirecan et al. [27] to win the
ICPR 2012 mitosis detection challenge where the task was to identify nuclei in mi-
totic phase within WSIs. While mitosis are normally rare and well-separated, they
are very hard to differentiate from non-mitotic nuclei and the ratio of mitotic to
non-mitotic nuclei is generally very low in a tissue slide. Hence, training datasets
composed of randomly sampled patches generally suffer from high class imbalance.
To overcome this problem, different techniques have been proposed. First, the most
straightforward approach consists of sampling balanced datasets and using data
augmentation strategies to augment the dataset for positive cases by replication as
well as additional forms of augmentation based on affine transforms [61]. Another
approach is to leverage non-expert annotated datasets and learn from crowds. Al-
barquouni et al. [12] proposed AggNet, a CNN model for mitosis detection that can
directly handle data aggregation in the learning process such that image annotation
from non-experts can be leveraged during training. Specifically, AggNet consists of
multi-scale CNNs that are first trained with expert annotations and tested on data.
The output after this first round of training is sent to crowdsourcers for relabeling
the mistaken annotated images. Then, the networks are refined using the collected
annotations and used to generate new ground truth labels.
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Finally, another category of works leverages unsupervised learning. Xu et al. [105]
proposed a SSAE for nuclei detection in breast cancer images. Their model is first
trained in an unsupervised setting with a reconstruction loss and a sparsity con-
straint. Then, a softmax layer is added as penultimate layer and the model is
fine-tuned to classify nuclei patches from non-nuclei patches. At inference, a sliding
window method is employed to detect all nuclei within the new tissue slides. Song
et al. [86] proposed a hybrid deep auto-encoder to extract high level features from
input patches and created probability maps that capture the different shape of nuclei
using a Gaussian filtering of image patches centered on cells. The auto encoder is
trained to reconstruct the input RGB image as well as the corresponding generated
probability map. The predicted detected center points of nuclei are obtained by
applying the deep auto encoder to unseen patches and using a second model, here a
CNN or SSAE, to perform cell classification on the resulting predicted centers. In an
extension [85] to this first work, the classification CNN and the SSAE were coupled
to create a model that first detects then classifies cells in WSIs. The coupling is
done by adding two branches to the auto encoder: one classifies the detected cells
and the other predicts probability maps.
4.3.2 Regression Models
Regression models for cell and nuclei detection were proposed to efficiently locate the
centroid of objects. In fact, while CNN classification models produce relatively good
results on detection tasks, they do not consider the topological domain on which the
output detection resides. In regression analysis, given an input and output pair, the
task is to estimate a function that represents the relationship between both variables
where the output does not only depend on the input but also on a topological domain
(e.g. spatial domain, time).
Most works that address the detection of histology primitives with a regression
model define a training output as a proximity score map, which indicates the prox-
imity with respect to the centroid of the object of interest. Generally, the proximity
score map is defined as a function resulting in high peak values in the vicinity of the
center of the object. For instance, Chen et al. [25] defined the proximity score map
as:
s(l) =
{
0 x 6∈ M
e−
||l−c||2
2σ2 x ∈M (4.7)
where l is the position of a pixel in the input patch with respect to the closest
centroid c of the object of interest (i.e. mitotic nuclei),M corresponds to a ground
truth segmented mask composed of annotated objects and σ is a hyperparameter
controlling the variance.
The model is trained with a per-pixel regression loss that minimizes the L2 norm
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between the predicted proximity score map and s(l). In the deep regression CNN
model, an FCN architecture is proposed with an upsampling layer that is used to
predict a proximity score map of similar size as the ground truth map s(l). Xie
et al. [101] proposed a similar regression CNN for detecting cells in breast, cervex
and neuroendocrine tumor tissues but used a weighted L2 loss formulated such that
higher penalties are applied for errors on predicted pixels that are closer to the
centroid of the cells.
Sirinukunwattana et al. [83, 84] introduced a new CNN layer designed for spa-
tially constrained regression to detect epithelial tumor nuclei in breast and colon
cancer datasets. The CNN predicts probability values that are topologically con-
strained such that high values are concentrated in the vicinity of the center of nuclei.
In the spatially constrained CNN architecture, the two penultimate layers are defined
to impose these spatial constraints. Specifically, the second to last layer outputs a
parameter vector θ(x) while the final layer outputs a probability map yˆ with highest
values at the pixels that are strong candidates for being the centers of tumor nuclei
such that:
yˆj ∝

(
1
1+ 1
2
||zj−zˆ0m||2
)
hm if ∀m 6= m′ ||zj − zˆ0m||2≤ ||zj − zˆ0m′||2
0 otherwise
(4.8)
where z0m represents the coordinates of the center of them
th annotated nucleus within
a given patch, zˆ0m is the m
th estimated nuclei center and hm ∈ [0, 1] is the height of
the output probability mask and is a trainable parameter defined as the output of
the layer before last. The model is trained with a weighted cross entropy loss that
penalizes wrong predictions compared to a pre-computed ground truth regression
mask. Finally, to detect the center of nuclei on large test image, the sliding window
strategy with overlapping windows is used and the predicted probability of being
the center of a nucleus is generated for each of the extracted patches using eq.(4.8).
These results are then aggregated to form a probability map where for each pixel
location the probability values from all overlapping patches containing the given
pixel are averaged. The final detection is obtained from the local maxima found in
the probability map. This spatially constrained regression CNN was improved in the
work of Kashif et al. [47] where the authors utilized a set of handcrafted features
(i.e. color features after color decomposition to isolate hematoxylin channel and
texture features based on the scattering transform [60]) as additional inputs to the
network and empirically showed sharper prediction results with lower false negative
nuclei detection.
To constrain the regression model, Xie et al. [100] proposed a CNN-based ap-
proach for nuclei localization that mainly consists of two steps. First, patches ex-
tracted from a WSI are assigned a set of voting offset vectors that correspond to
a preset number of voting positions, and a corresponding voting confidence score
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used to weight each vote. Then, the weighted votes are collected for all extracted
patches and a final voting density map is computed for the input WSI. The final
nuclei positions are identified by the local maxima of the density map.
Generally, detecting cells and nuclei is a first step towards counting or extracting
quantitative measures such as nuclei size or total count of cellular structures in a
WSI. Another direction for cell/nuclei analysis is to directly predict the desired
measurement. Xie et al. [99] proposed to bypass cell detection and directly estimate
the total count of cells in histopathology images using a density estimation approach.
Specifically, the cell counting problem is cast as a supervised learning problem that
tries to learn a mapping from an input image patch to a density map which is a
function over pixels in the image that is used to get an estimate of the number of
cells in the image after integration. To learn this mapping, the authors proposed a
fully convolutional regression network that is trained to regress ground truth density
maps from the corresponding input image patches. The model is trained using the
mean square error between the predicted heat map and the target density map. At
inference, given an input image patch, the model predicts a density map. Two FCN
architectures inspired by the VGG-Net architecture adapted with different receptive
fields were tested. The authors observed that using larger receptive fields worked
best when cells were organized as clumps (where multiple cells overlap) and hence
covered larger image patches.
4.3.3 Segmentation Models
Another approach for automating the analysis of histologic primitives is through
analyzing the shape and morphology of cells, nuclei, glands or other tissue com-
ponents. To do so, detection only is not sufficient and a pixel-level delineation of
these components is better suited. However, segmentation in digital pathology is
often challenging given the high resolution nature of WSI and deep learning models
tend to be computationally inefficient on such large images. Most existing deep
segmentation models are supervised models that leverage fully convolutional archi-
tectures trained with a per-pixel cross entropy loss. In fact, during the 2015 MIC-
CAI Gland Segmentation Challenge [82], the top-5 teams used FCN architectures
with different pre and post processing strategies. The challenge winning model [24]
was a FCN model with auxiliary layers trained to simultaneously predict a gland
boundary mask and a gland mask. Using the auxiliary loss functions as a form of
regularization helped training a segmentation model that would converges to more
plausible segmentation results in which gland boundaries are not clustered. Such
additional domain specific knowledge is often critical when training deep models in
digital pathology, especially given the scarcity of the dataset available. We discuss
the most representative variants of FCNs in digital pathology below.
Song et al. [88, 87] proposed a multi-scale CNN architecture to segment cervical
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cytoplasm and nuclei. The WSI is partitioned into patches extracted at multi-
ple scales and a CNN is trained for each scale to classify the central pixel of each
patch as nuclei, cytoplasm or background. Feature maps from different scales are
then concatenated and a final segmentation mask is obtained using a graph parti-
tioning technique on the extracted features. At inference, the trained multi-scale
CNN is applied in a sliding window fashion. Bel et al. [32] also showed the ad-
vantage of using a multi-scale CNN model trained with patches extracted at two
magnification levels (i.e. 20x and 40x) over a FCN for segmenting nine classes of
renal structures. Janowczyk et al. [45] proposed a resolution adaptive deep hier-
archical learning framework which uses multiple deep learning networks, with the
same architecture, to significantly reduce computation time for fully segmenting
high-magnification digital pathology images. Raza et al. [73] also used multiple res-
olution input patches to train a FCN for segmenting cells in fluorescence images
but in contrast to other works, their proposed network uses intermediate layers in
the network architecture to enforce better localization and context. The proposed
network consists of multiple convolution followed by tanh activation, pooling and
upsampling layers. Features from different layers are concatenated to enforce in-
formation flow from lower layers of the network to deeper layers. Auxiliary losses
are added at different intermediate layers to penalize segmentation errors at cell
borders.
Another challenge in segmenting nuclei and cells in WSI is the potential overlap
between neighbouring structures which can alter the cell/nuclei shape and bound-
aries appearance. In order to preserve shapes many works rely on imposing higher or-
der penalties when training segmentation models. While FCNs are generally trained
with per-pixel cross entropy loss functions that do not necessarily encode specific
shape priors, their output probability maps have been shown useful as unary terms
in energy based segmentation models. Xing et al. [103] used such strategy to seg-
ment tumor nuclei from overlapping clumps and showed that the probability maps
obtained from a trained FCN model formed a robust initialization step for a level
set model.
As for detection, segmentation can also be bypassed to directly predict the de-
sired quantification of histologic primitives. For instance, Veta et al. [92] proposed to
avoid the nuclei segmentation step and directly predict the nuclear area which is pre-
dictive of outcome for breast cancer patients. The authors train a CNN model that
is applied locally at each given nucleus location to measure the area of individual
nuclei.
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4.4 Large tissue analysis and Prediction Models
Often, the purpose of many tasks in digital pathology, such as counting mitoses,
quantifying tumour infiltrating immune cells, analyzing the shape of glandular struc-
tures of specific tissue entities aim to ultimately predict patient outcome. Therefore,
an interesting question is whether these intermediate proxies for outcome could be
bypassed and the novel deep learning techniques could be used to directly learn
diagnostically relevant features in microscopy images of the tumour, without prior
identification of the known tissue entities, e.g., mitoses, nuclear shape, infiltrating
immune cells. Different works attempted to train deep learning models using pa-
tient outcome as the endpoint to see if such model could reveal known prognostic
morphologies, but also has the potential to identify previously unknown prognostic
features [17]. We review some of these works in the following section.
4.4.1 Deep Classification and Segmentation Models for Can-
cer Diagnosis
Given a WSI, automatic cancer diagnosis is generally formulated as assigning a class
label to an entire tissue slide (i.e., WSI classification) or identifying abnormal areas
of tissues (i.e., WSI segmentation). The majority of existing deep models proposed
for predicting the presence of cancer from WSIs use CNNs and FCNs.
There are three main challenges in designing CNN models for cancer prediction
from WSIs. All of these challenges arise from the high dimensionality of tissue slides
and the limited available annotations for training and validating supervised mod-
els. As mentioned in section 4.1, patch-based representations are unavoidable but
come with different shortcomings. In this section, we discuss the different strategies
proposed for i) training supervised patch-based prediction models using fine-level an-
notations (i.e., delineations of abnormal tissue areas in a WSI), ii) training weakly
supervised patch-based prediction models using only slide-level annotations (i.e.,
benign vs malignant WSI), iii) encoding the topology of tissues by leveraging the
multi-magnification nature of WSIs.
4.4.2 Fully Supervised Models
In fully supervised settings, cancer prediction models can be trained on finely anno-
tated datasets in which one (or several) expert(s) highlighted abnormal areas (e.g.,
cancerous tissue) within a WSI. In fact, in most applications, only a small portion
of the imaged tissue caries morphological and structural patterns indicative of ab-
normalities. Delineating such areas can be very complex and time consuming as it
involves visually identifying abnormal patterns at different magnification levels.
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Different works proposed CNN classifiers trained on patches extracted from an-
notated WSIs to predict the presence of cancer or cancer subtypes. In most works,
a fixed magnification level is selected (generally 20x or 40x) and patches are sam-
pled from the set of annotated training WSIs. Sampling strategies in cases where
pixel-level annotations are available, involve constructing training mini-batches by
randomly selecting samples from points inside and outside the annotated area but
within the tissue (i.e., discarding background). For each mini-batch the number of
samples per class is generally determined with uniform probabilities [18, 17, 71, 30]
and the patch size is often large enough to include structural information (e.g.,
224 × 224). This strategy can work poorly and result in very imbalanced mini-
batches in cases where only a fraction of the tissue contains abnormality. This can
be the case, for instance, for breast cancer metastasis detection in sentinel lymph
nodes where often, only a minuscule fraction of the slide contains cancer and most of
the slide is covered by lymphocytes. Also, certain normal regions which look more
similar to cancer are typically underrepresented in the training data and patch-
based CNN models are generally not capable of correctly identifying these areas
as normal. To address this problem, Litjens et al. [56] used a boosting approach
to sample training mini-batch patches. This consists of using the initial prediction
score maps obtained for the training dataset to sample new patches for both can-
cerous and non-cancerous classes while increasing the likelihood of sampling patches
that were originally incorrectly classified by the model. This process results in addi-
tional training data which contains more difficult samples. Subsequently, the model
is re-trained using the new sampled patches.
Once the patch-level classification model is trained, it can be used in a sliding
window fashion to classify all patches in an unseen WSI and obtain a prediction score
map highlighting areas predicted as cancerous. To obtain a slide-level prediction for
the entire WSI from the predicted score map, different aggregation techniques have
been proposed [58]. Some works simply use the maximum value in the predicted
probability score map as the slide-level prediction [104, 58]. One strategy that
was shown successful on different datasets [38, 71, 18, 40, 17] consists of leveraging
domain knowledge to extract additional hand-crafted features from the predicted
score map and train a subsequent classifier to predict a slide-level label. Wang et
al. [94] adopted this strategy to win the Cameleyon [18] challenge on identifying
metastatic breast cancer from lymph node WSIs. Specifically, 28 geometrical and
morphological features were extracted from each predicted score map, including the
percentage of tumor region over the whole tissue region, the area ratio between tumor
region and the minimum surrounding convex region, the average prediction values,
and the longest axis of the tumor region. A random forest classifier is then trained
to discriminate WSIs with metastases from the ones without using the hand-crafted
features.
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4.4.3 Weakly Supervised Models
Weakly supervised models leverage patch-based representation to classify WSIs
while only using slide-level annotations during training. Among the works we sur-
veyed, there exist different strategies for training a prediction CNN model using
slide-level labels, we present them below.
One commonly used strategy consists of extrapolating the labels from the slide-
level to all patches sampled from a given WSI, train a patch-level classifier then use
max-voting or pooling to infer the slide-level class. This strategy can be used for
patch-level segmentation with FCNs [72] as well as WSI classification [18]. Depend-
ing on the complexity of the task and the disparity among patches, this strategy can
produce relatively good results. More sophisticated approaches adopt the multiple
instance learning framework [46, 43]. For instance, Hou et al. [43] aggregate the
prediction of a patch-based CNN model using an Expectation-Maximization (EM)
based decision fusion model to automatically locate discriminative patches. In the
authors’ formulation, a WSI X(i) is represented as a bag (using the MIL terminol-
ogy) of instances (i.e., patches) (x
(i)
1 ,x
(i)
2 , . . . ,x
(i)
P ) where P is the total number of
instances per bag. Ground truth labels are only available at the bag level. Hid-
den binary variables H(i) are introduced to model whether an instance of a bag is
discriminative or not. Each instance is associated with a hidden variable such that
h
(i)
p represents the hidden variable associated with patch p. Assuming all bags and
instances are independent, the decision fusion model is defined as follows:
P (X, H) =
N∏
i=1
P∏
j=1
(
P (x
(i)
j |h(i)j )
)
P (H(i)), (4.9)
where N is the total number of training WSIs. The likelihood of the data P (X) is
maximized using the EM algorithm and the instance that maximizes P (h
(i)
j |X(i)) is
defined as the discriminative instance for the positive bag. Discriminative instances
are selected to continue training the CNN prediction model.
Nazeri et al. [67] proposed a two-Stage CNN for classifying breast cancer WSIs.
A first CNN, called patch-wise network is trained on patches and outputs spatially
smaller feature maps. A second CNN network (named image-wise network) which
performs on top of the patch-wise network, receives stacks of feature maps as in-
put and generates slide-level prediction scores. In this cascaded configuration, the
second network learns relationships between neighbouring patches represented by
their feature maps. The patch-level labels are unknown yet the patch-wise network
is trained using the CE loss based on the label of the corresponding WSI. Once
trained, the last fully connected layer of the patch-wise network are discarded and
only the feature maps obtained from the last convolutional layer are used. The
image-wise network is trained on the feature representations obtained from non-
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overlapping patches using the CE loss again.
Other works proposed to use domain knowledge to identify discriminative patches
without requiring patch-level annotations. For instance, Ertosun et al. [34] observed
that the grading of gliomas is highly correlated with nuclei morphology, hence, tissue
areas with abundant nuclei distribution should be more reflective of the slide-level
glioma grade. Based on this observation, the authors trained a CNN model on
patches extracted after automatic nuclei detection and showed improved perfor-
mance against randomly sampled patches.
4.4.4 Encoding Structural Information
Capturing high-level contextual information with patch-based representations is gen-
erally difficult as it involves handling larger input image sizes, which does not work
well when training deep models. In order to capture context, different works attempt
to encode structured relations between neighbouring patches.
One strategy to encode larger context is to employ larger input patches when
training the deep prediction models. This strategy was explored by Bejnordi et
al. [19] witch stacked multiple CNN models trained sequentially with input patches
of increasing size in order to learn fine-gained (cellular) information and global
interdependence of tissue structures. The authors leveraged the FCN architecture
to train the model with patches of increasing size. Specifically, a first CNN model
is trained to classify patches of size 224× 224. After convergence, this first model is
freezed and converted into a FCN architecture by removing the last fully connected
layers. A second network is then stacked on top of the FCN and is similarly trained
to classify patches. The input to the second network are the feature maps output of
the first FCN. In this cascaded architecture, the second model is trained with input
patches with larger size.
Other strategies to encode larger context involve using LSTM units. Agarwalla
et al. [10] combined the different feature representations obtained from a patch-
level CNN using a 2D LSTM network to encode neighbouring relationships between
patches. A 2D-grid of features is generated by packing feature vectors for neigh-
bouring patches in the WSI then four 2D LSTMs running diagonally are used to
capture the context information by treating WSIs as a two-dimensional sequence
of patches. Finally, tumour predictions across all the spatial dimensions are av-
eraged together to get the final slide-level class label. Similarly, Kong et al. [50]
combined CNNs and 2D LSTMs to encode structure between neighboring patches
for classifying metastatic tissue slides. The spatial dependencies between patches
are explicitly modelled via an additional custom loss function which penalizes the
CNN from predicting diverging probability scores for neighbouring patches in a 4-
connected neighbourhood.
Finally, Wang et al. [95] attempt to encode structural information related to the
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contours of microinvasive cervix carcinoma regions in WSIs. Explicitly formulating
domain knowledge related to membranes organization is difficult, especially when
such information needs to be encoded within a deep learning model. Wang et al.
[95] trained a segmentation FCN model to segment basale membranes of cervix
carcinoma tissues. In order to augment the FCN with additional information related
to the organization and structure of the membranes’ contours, the authors leverage
adversarial training and include a GAN model in which the generator is replaced by
the FCN segmentation model and the discriminator learns to identify ground truth
membrane contours from predicted segmentation contours.
4.4.5 Survival Prediction Models and Multimodal Applica-
tions
Survival analysis is the task of predicting the time duration until an event occurs,
which, in digital pathology, corresponds to the death of a patient. In survival
datasets, each patient (i) is labelled with a pair (t(i), δ(i)) corresponding to an ob-
servation time and a censored status. A censored patient (i.e., patient for which the
event is not observed) is characterized by an indicator variable δ(i) = 0 while an
uncensored patient (i.e., patient for which the event occurred during the study) is
characterized by δ(i) = 1. The observation time t(i) can be either a survival time S(i)
or a censored time C(i) determined by the status indicator variable δ(i). The most
popular survival model is Cox proportional hazard model [28] which is built on the
assumption that a patient’s survival risk is a linear combination of covariates (e.g.,
structured data such as patients’ sex, smoking years, age). However, linear models
are not the best suited to model interactions in real-world datasets. This motivated
research that leveraged the non-linear deep learning models as survival predictors.
We present some of the recent works below.
One way to leverage deep learning models in survival prediction tasks is to em-
ploy CNN features to discover new imaging biomarkers. For instance, Yao et al. [109]
trained a CNN model to identify cancer from non-cancer cells in tissue patches and
used the features from the last convolutional layer of the CNN to extract quantita-
tive descriptors such as textures and geometric properties (e.g., cell area, perimeter,
circularity). The extracted features are used to discover imaging biomarkers that
correlate with patient survival outcomes using the multivariate cox proportional
Hazard model. The authors showed that imaging biomarkers from subtype cell
information can better describe tumor morphology and provide more accurate pre-
diction than other techniques relying od molecular profiles. Similarly, Bychkov et
al. [22] showed that CNN-derived features extracted from segmented images of ep-
ithelium, non-epithelium, and unsegmented tissue micro-array cores correlated well
with five-year survival. Bauer et al. [15] showed that a CNN model could be used
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to classify nuclei in different tissue types (i.e., prostate cancer and renal cell cancer)
and that the combination of tissue types during training could increase the overall
survival analysis. Zhu et al. [114] showed that the integration of CNN-based features
with genomic features into a Cox survival prediction model revealed complementary
information on tumor characteristics between pathology images and genetic data.
Other methods employ CNNs to directly predict the survival risk factor. Zhu et
al. [113] developed the first deep CNN for survival analysis (DeepConvSurv) with
pathological images. The model is trained on patches extracted from tissue areas
delineated by experts to regress the survival time for each patch.
L = −
∑
i∈U
(
βTa(i) − log
∑
j∈ω(i)
eβ
T a(j)
)
, (4.10)
where βTa(i) is the risk associate with the input image with β corresponding to the
weights of the final fully connected layer and a(i) are its input activations. U and
ω(i) represent the set of right-censored patients (i.e., cases for which the event did
not occur at the time of the study) and the set of patients for which the event occurs
after t(i).
The authors extended this model to predict survival outcomes for an entire WSI
(i.e., a collection of patches) [115]. In this extension, multiple patches are extracted
from a given patient’s WSI and clustered based on their phenotype with a k-means
clustering approach. Then, clusters are selected based on a their patch-level survival
prediction performance using the Cox regression model for predicting survival. The
selected clusters are then used to train the DeepConvSurv model described above.
All cluster-level survival predictions are then aggregated to obtain a final survival
prediction score for an entire WSI.
In practice, patient diagnostic is generally based upon the integration of differ-
ent sources of information (e.g., omics, radiology, patient history). Consequently, it
may be beneficial to integrate these different sources of information into the auto-
matic prediction systems as well. Recent works have attempted to design survival
prediction models that integrate both genomic biomarkers and digital pathology
images. Yao et al. [110] used a survival CNN model trained on such multi-modal in-
puts to predict time-to-event outcomes. Their framework showed superior results to
the clinicians’ decision rules for predicting the overall survival of patients diagnosed
with glioma. Given the current trend in personalized medicine, such multi-modal
approaches are becoming more and more critical.
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4.5 Non-clinical Tasks
In this section we present categories of work that do not directly attempt to automate
clinical tasks but rather focus on facilitating computer-aided diagnosis by improving
the quality of input images and datasets to facilitate training or introduce ways to
design more interpretable deep learning models.
4.5.1 Stain Normalization, Computational Staining and Aug-
mentation
Stain normalization has always been a critical step in the training of machine learn-
ing models. In fact, in contrast to pathologists, most existing machine and deep
learning models are sensitive to variations in the staining appearance of tissue slides.
Deep learning models were applied in various ways to normalize stains across
datasets. Janowczyk et al. [44] proposed to use features learned with a SAE to
normalize stains in different images to a template image. This process was applied
by clustering the pixels in a sparse auto-encoded feature space so that respective
tissue partitions could be aligned using their respective color distributions. By using
individual tissue partitions, this approach is able to more sensitively modify the color
space as compared to a global method where all pixels are considered concurrently.
GANs have also been employed to normalize stains. Zanjani et al. [111] trained
a conditional GAN to generate a colorized H&E image in its CIEL*a*b* space
using as input the image lightness channel and a set of structured latent variables
drawn randomly from a prior distribution. Finally, Cho et al. [26] defined the
problem of stain normalization in the context of domain adaptation and combined
it with a prediction task within a GAN framework. The GAN loss described in
eq.(4.6) is combined with two additional regularization terms that aim at preventing
the degradation of a task-specific network on synthetic images and enforce similar
features between synthetic and original images in order to facilitate the task of the
generative model.
Conditional GANs were also used in the context of digital staining where the task
is to generate images artificially stained with different staining agents. Burlingame
et al. [21] used a GAN to convert H&E images to immunofluorescence. Bayramoglu
et al. [16] employed a similar conditional GAN to virtually stain unstained hyper-
spectral specimens.
Finally, GANs have also been employed as data augmentation tools to generate
synthetic images. Senaras et al. [80] and Moeskops et al. [65] used a GAN to
generate synthetic images and showed that using the synthetized images to augment
training datasets increased the performance of prediction and detection models when
compared to other standard augmentation strategies.
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4.5.2 Interpretability
One recurring critique made against deep learning and machine learning models is
their lack of interpretability. Generally, interpretable models in digital pathology
are ones for which the output is jutifiable. Deep learning models do not a priori fit in
this category and are commonly seen as black-box computational tools. Introducing
novel ways to gain insight into the decision making process of deep learning models
has become an active area of research in digital pathology.
Cruz-Roa et al. [31] proposed to interpret the predictions of a CNN used to
identify cancer in WSIs. Their strategy for interpretability consists of including an
interpretable layer that highlights the visual patterns contributing to discriminate
between cancerous and normal tissues patterns, working akin to a digital staining
which spotlights image regions important for diagnostic decisions. This is achieved
by multiplying the feature maps of the trained CNN model by the final layer’s soft-
max classifier weights. All weighted feature maps are combined into an integrated
feature map and a sigmoid function is applied at each pixel of the resulting map.
The map is used to highlight areas of the image that were scored as highly discrimi-
native of cancer. While this approach gives a relatively good insight into the trained
models’ predictions, it does not really capture the intermediate layers’ contributions
to the final outcome.
Korbar et al. [51] proposed a visualization approach to identify discriminative
features for colorectal polyps in WSI. In their work, the FCN nature of ResNets
is leveraged to directly correlate features with salient areas at each layer. Specifi-
cally, the authors used a gradient-based approach to identify discriminative features
learned at each intermediate layer of the trained ResNet model. Gradients reflect
the change of each intermediate layer function with respect to the input. Hence,
visualizing the resulting gradient maps can provide relevant insight on the features
distribution per class. However, gradients have generally high variance at interme-
diate layers and they can be influenced by all different output classes. The authors
used a variant of gradient based visualization technique name the class activation
map which looks at the change in the penultimate layer’s activations after a single
backpropagation pass. A class activation map for a particular class indicates the dis-
criminative image regions used by the CNN to identify that class. The utility of this
approach in identifying areas of the input image that justify the most the models’
prediction was tested by comparing the obtained class activation maps with expert
annotations. The method showed promising results and relatively good estimates of
decisive regions and features for different types of polyps were obtained.
These techniques are a first step toward gaining more insight on the training
and output predictions obtained from deep learning models. At a clinical level,
interpretability offers a potential avenue for introducing deep learning models into
clinical workflows, hence, we can expect future works to continue pursuing this area
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of research.
4.6 Validation Strategies
A wide variety of metrics have been used to validate the different deep learning
models. In the works we reviewed, accuracy, F1 score, precision, recall and area
under ROC curve (AUC) were used in majority to evaluate detection and predic-
tion models. Depending on the application, the performance can be reported at
the patch or slide-level. Dice scores and FROC are generally used for evaluating
segmentation models and measuring the overlap between the predicted segmenta-
tion mask and the ground truth annotation. Veta et al. [92] used the Bland-Altman
method to evaluate the agreement between two sets of measurements (i.e., predicted
vs measured nuclei area). For generative models used in stain normalization tasks,
there was no common metric used among the works we surveyed. In fact, some
works chose to evaluate the color constancy of the stain normalized images and
used the normalized median intensity, others focused on perception-based metrics
and reported the accuracy of experts attempting to differentiate synthetic from real
images after stain normalization.
To evaluate the performance of prediction models, a few works attempted to
compare the performance of the proposed deep learning models with experts on
similar test sets. Different metrics have been used to compare humans to machines.
For instance, agreement between experts and automatic systems is ideally quantified
using the Kappa score. Another approach involves comparing the AUC of an auto-
matic system to the average sensitivity and specificity of different experts. While
this is not a completely fair comparison, it gives a relatively good estimate of how
far are current systems from becoming part of clinician’s workflow.
With the increase of available public datasets and the emergence of many chal-
lenges and competitions, the use of cross-validation techniques to evaluate machine
learning systems has reduced. In fact, most released datasets as part of competi-
tions are split into training, validation and test sets and these splits are generally
kept fixed to facilitate comparison between the competing methods. This strategy,
however, does not allow models to be tested on different training sets.
There exist different types of annotations used in the datasets surveyed in this
report. Most datasets were annotated by one (or more) pathologist at the slide
or patch level and only a few public datasets provide annotations confirmed by
immunohistochemistry, genetics or patient’s outcome. Annotations obtained from
experts can be imperfect, especially in tasks such as segmentation of cancer areas
where human subjectivity is unavoidable. Also, appropriate use and interpretation
of annotations collected from multiple experts remains an open challenge. The gold
standard in digital pathology is generally seen as the survival outcome of the patient
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or their molecular profiling. However, a model that predicts cancer from patient’s
survival unavoidably makes strong assumptions regarding the causal relationship
between the patient’s observational data (i.e., a digital pathology slide) and their
outcome. Verifying the statistical prevalence of such relationship is impossible.
With the increasing number of large dataset collections made publicly available,
we can expect evaluation metrics and validation strategies to become more and more
standardized.
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Chapter 5
Summary and Discussion
Since the adoption of the digital slide for clinical diagnosis there has been a gradual
evolution over the years aimed at reducing manual intervention and automating
pathologists’ workflow. In the initial phase of digital pathology, traditional computer
vision methodologies were used for tissue detection, segmentation, morphometry,
and a plethora of other tissue analysis tasks. The main challenges for designing
accurate systems are the variability in staining of tissue slides, slide preparation and
artefacts resulting from the digitization process.
One particularity of the WSI is its high dimensionality which allowed for early
applications of deep learning models with patch-based representations as it provided
large enough training sets obtained by sampling patches from the large tissue slide.
The studies presented in this survey report the state-of-the-art performance on most
WSI analysis tasks (i.e., analysis of histology primitives and outcome prediction)
and are all based on (or leverage) patch-based deep learning models. These models
have enabled accurate prediction models as well as techniques for identifying and
extracting discriminative information from complex tissue images.
While computational imaging with deep learning models can clearly play a role
in better quantitative characterization of disease and precision medicine, there still
remain a number of substantial technical and computational challenges that need
to be overcome before computer assisted image analysis of digital pathology can
become part of the routine clinical diagnosis. Although some of the existing deep
learning models were designed to overcome challenges related to the WSI size (e.g.,
patch-based strategies, efficient sampling techniques, faster operations via improved
hardware or sparser models), processing the multi-magnification tissue slide without
loss of context or structural information remains unsolved. In fact, most of the
models employed in the current works are not designed for large input sizes. There
is also a need for more standardized and clinically relevant validation protocols as
currently none of the existing works were tested on real clinical cohorts. On a
similar note, designing automatic cancer diagnosis systems is still an open problem
that arises from the lack of available annotated datasets as there is generally no clear
clinical consensus on subtyping cancers. Ultimately, the clinical applicability of any
deep learning based prediction system will unavoidably result from a collaborative
effort between pathologists and computational scientists in order to clearly identify
relevant clinical problems and accurately interpret the available annotations.
Aside from improving the performance and interpretability of existing systems,
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there are many novel directions that could be explored. With the availability of
larger datasets such as the TCIA [2] and TCGA [1] data sharing portals, models
that can leverage a fusion of modalities (e.g., genomics, histopathology, radiology)
for better predictive modelling could be an application area for deep learning. There
are also exciting opportunities in leveraging deep models to improve the digital
slide acquisition procedure with learning based approaches for signal reconstruction
but also flagging systems that can identify altered digital slides (due to staining,
fixation or any other artefact caused by the image acquisition) and alleviate the
need for manual interventions during the digitization process. On the technical
side, the emergence of new datasets such as PCam [7] which is the first dataset for
digital pathology that includes more than 300,000 images of size 32×32, brings new
opportunities for developing and evaluating customized deep network architectures
that are inspired by the challenges proper to tissue images. For instance, one active
area of research in this direction is the design of rotation invariant CNN models.
To conclude, by all indications, the digitization of tissue glass slides and the
large adoption of deep learning models as computation models is showing significant
potential for a transformation of the field of digital pathology from qualitative to
quantitative.
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Table 5.1: Public Datasets for Image Analysis Tasks in Digital Pathology.
Dataset Task #Images
Arganda et al. [13] Neuron boundary segmentation 60
ISBI2012-EM [4] Neuron segmentation 30
GlaS [82] Colon gland segmentation 160
AMIDA2013 [93] Mitosis detection
ICPR 2012 [27] Mitosis detection 50
ICPR 2014 [27] Mitosis detection 50
TUPAC [9] Tumor detection 300
Camelyon16 [18] Metastasis detection 299
Camelyon17 [18] Metastasis detection 400
TMA Thyroid [8] Outcome prediction
BACH [6] Tissue subtypes classification 400
TCIA [2] Multiple –
TCGA [1] Multiple –
Her2 [71] Her-2 Scoring 172
Cellavision [3] Cell segmentation 100
Enjoypath [5] Multiple 318
PCam [7] Metastasis detection 327680
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Table 5.2: Deep Learning Models for Digital Pathology Applications. The nomenclarture used in this table is as
follows. PP:Pre-processing, Augm.:Augmentation, Annot.: annotations, CONV:convolution layer, MP: max pooling,
ReLU: rectified linear units, FC: fully connected layer, BN: batch normalization, UP: upsampling, ELU: exponential
linear unit, LRN: local response normalization, lReLU: leaky ReLU, ADV: adversarial loss, ConfMat: Confusion
matrix, TPV: true predictive value, PPV: positive predictive value. Values separated by ”/” correspond to different
datasets used in the corresponding study.
Method Site Stain Mag. Task #WSI #Annot.Public Data Input Size PP Augm. Model #Layers Ops Cost Performance
[27] Breast H&E 40x Mitosis detection 50 300 ICPR2012 101× 101 – Rotations,
Mirroring,
Flip
CNN 13 CONV,
ReLU,
MP, FC
CE P=0.88,
R=0.70,
F1=0.78
[61] Breast H&E 40x Mitosis detection 50 300 ICPR2012 72× 72 – Rotations LeNet-5 7 CONV,
Tanh,
MP, FC
CE F1=0.66
[96] Breast H&E 400x Mitosis detection 50 300 ICPR2012 80× 80 – Rotations,
Mirroring
CNN 3 CONV,
ReLU,
MP, FC
CE F1=0.73
[23] Breast H&E 40x Mitosis detection 50 300 ICPR2014 94× 94 – – FCN 16 CE F1=0.79
[12] Breast H&E 40x Mitosis detection 23 – AMIDA2013 33× 33 – Rotation,
Mirror-
ing,Crowd
CNN 5 CONV,
ReLU,
MP, FC
CE AUC=0.86,
F1=0.61
[76] Breast H&E 40x Mitosis detection 174 AMIDA 64× 64 – – CNN 5 CONV,
ReLU,
MP, FC,
BN
CE F1=0.56
[75] Breast H&E 20x Tubule detection 174 7513 – 64× 64 – – CNN 5 CONV,
ReLU,
MP, FC
CE F1=0.59,
P=0.72,
R=0.56
[48] Brain
Breast
H&E 40x Nuclei detection 29 13766 – 51× 51 SN – CNN 3 CONV,
ReLU,
MP, FC
CE P=0.69,
R=0.74,
F1=0.72
[105] Breast H&E – Nuclei detection 535 3500 – 34× 34 – – SSAE 2 FC CE AP=78.83
[49] Brain
Breast
H&E – Nuclei detection 29 13766 – 51× 51 – – VGG 3 CONV,
ReLU,
MP, FC,
DO
CE F1=0.84,
R=0.81,
P=0.88
[11] Blood
Brain
Bone
Marrow
Fluo 40x Cell detection 184 – Fluo-HeLa 53× 53 – – FCN 7 CONV,
ReLU,
MP, FC
CE IOU=0.72
[97] Lung H&E – Cell detection 300 – – 40× 40 – – LeNet-5 7 Sparse-
CONV,
ReLU,
MP, FC
CE F1=0.82
[57] Lung Neu-
rons
H&E 40x Cell detection 16/24 150 – 31× 31 – Rotations CNN 5 CONV,
ReLU,
MP, FC
CE F1=0.90/0.92
[68] Lung H&E – Cell detection 215 83245 NLST 20× 20 – – CNN 7 CONV,
ReLU,
MP, FC
CE F1=0.79
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Method Site Stain Mag. Task #WSI #PatchesPublic Data Input Size PP Augm. Model #Layers Ops Cost Performance
[106] Lung H&E 40x Cell detection 215 83245 NLST 20× 20 – – LeNet-5 5 CONV,
ReLU,
MP, FC
CE F1=0.79
[107] Lung H&E 40x Cell detection 215 83245 – 20× 20 – – AE 2 FC CE F1=0.83
[86] Bone Mar-
row
H&E – Cell detection 52 5248 – 29× 29 CD – AE 8 FC CE P=0.92,
R=0.97,
F1=0.94
[85] Bone Mar-
row
H&E – Cell detection 52 5248 – 29× 29 CD – AE 2 FC CE P=0.92,
R=0.97,
F1=0.95
[36] Hep2 IF – Cell classification 83 13596 ICPR2014 78× 78 – Rotation AlexNet 7 CONV,
ReLU,
MP, FC,
DO
CE mACC=0.88
[41] Hep2 IF – Cell classif. 83 10000 ICPR2014 78× 78 – Affine CNN 5 CONV,
ReLU,
MP, FC
CE ACC=0.96
[112] Blood H&E 40x LKC classif. 18 1080 ISBI2012-EM 11× 11 – None CNN 4 CONV,
MP, FC
CE ACC=0.93
[63] MTC EM 20Kx MTC classif. 403 403 ICPR2012 400× 400 – Rotations LeNet-5 7 CONV,
Tanh,
SPM,
FC
CE CS=100
[61] Breast H&E 40x Mitotic grade 5 226 AMIDA2013 72× 72 – None CNN 10 CONV,
ReLU,
MP, FC
CE F1=0.66
[37] Neuron EM – Neuron segm. 30 – ISBI2012-EM 95× 95 – – CNN 10 CONV,
ReLU,
MP, FC
CE Inference
time(s)=15.05
[101] Breast H&E 40x Cell detection 32 – TCGA 49× 49 – – CNN 8 CONV,
ReLU,
MP, FC
WCE P=0.91,
R=0.91,
F1=0.91
[100] Neurones Ki-67 20x Nuclei detection 44 – – 39× 39 – – CNN 8 CONV,
ReLU,
MP, FC,
DO
WL2+L1 P=0.85,
R=0.79,
F1=0.81
[83] Colon
Breast
H&E 20x Nuclei detection 30 ICPR2014 27× 27 L*ab conver-
sion
Rotation
Morroring
CNN 6 CONV,
ReLU,
MP, FC
WCE P=0.71/0.73,
R=0.85/0.78,
F1=0.77/0.75
[84] Colon H&E 20x Nuclei detection 100 20K CRCHistoNuclei 27× 27 CD Affine CNN 8 CONV,
ReLU,
MP, FC
WCE P=0.75,
R=0.83,
F1=0.79
[47] – H&E – Nuclei detection 15 – – 27× 27 – – CNN 8 CONV,
ReLU,
MP, FC
CE P=0.77,
R=0.72,
F1=0.75
[99] Blood
Retina
H&E – Cell counting 2 7000 – 100× 100 – Synthetic IF
images
FCN 7 CONV,
ReLU,
MP, FC
L2 True/Estimated
count=705/696
[25] Breast H&E 400x Mitosis detection 50 300 – 2K×2K – – DeepLab 16 CONV,
ReLU,
MP, FC
CE F1=0.79
[92] Breast H&E 40x Nuclei area 39 4264 – 96× 96 – – CNN 10 CONV,
ReLU,
MP, FC
CE Bland-Altman
Bias=-2.98
[88] Cervex H&E 40x Cell segm. 50 8590 – 32× 32 YUV color
conversion
Multi-scale CNN 5 CONV,
Tanh,
MP, FC
CE DICE=0.95
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[45] Breast H&E 40x Nuclei segm. 137 12K – 32× 32 – Multi-scale,
Boosting
AlexNet 6 CONV,
ReLU,
MP, FC,
DO
CE F1=0.82,
TPV=0.81,
PPV=0.88
[87] Cervex H&E – Cell segm. 8 20-60 ISBI2015-CELL 32× 32 YUV color
conversion
Rotations CNN 3 CONV,
ReLU,
MP, FC
CE DICE=0.89
[103] Brain
Breast
H&E – Nuclei segm. 30/35 600K – 55× 55 YUV color
conversion
Rotations CNN 6 CONV,
ReLU,
MP, FC
CE F1=0.77/0.78
[32] Kidney H&E 20x Kidney structures
segm.
15 3518 – 100× 100 Elastic U-Net 22 CONV,
ReLU,
MP, FC
CE ConfMat.
[82] Colon H&E 40x Gland segm. 165 – GLaS – SNlization Elastic FCN 16 CONV,
ReLU,
MP, UP
CE DICE=0.78,
Haus-
dorff=160.3,
F1=0.72
[24] Colon H&E 40x Gland segm. 165 – GLaS 480× 480 – Affine & elas-
tic
FCN 8 CONV,
ReLU,
MP, UP
Multi-
loss
DICE=0.78,
Haus-
dorff=160.3,
F1=0.72
[73] Pancreas IF 40x Cell segm. – 11K – 252× 252 Gaussian
noise lens
distortion
flip and
rotate
ResNet 50 Residual
blocks
WCE DICE=0.8, Ob-
jectDICE=0.84,
Haus-
dorff=27.5,
F1=0.72
[31] Skin H&E 10x Basal Cell Carci-
noma detection
1417 – BCC 8× 8 YUV conver-
sion
– SSAE CONV,
ReLU,AP,FC
MSE ACC=0.91
[29] Breast H&E 40x Ivasive Duc-
tal Carcinoma
detection
162 – – 100× 100 – Bootstrap CNN 3 CONV,
ReLU,
MP
CE ACC=0.84
[56] Prostate
Breast
H&E – Cancer detection 254/271– – 128× 128 – – CNN 6 CONV,
ReLU,
MP
CE AUC=0.99/0.88
[30] Breast H&E 40x Cancer detection 584 – TCGA 101× 101 – – CNN 3 CONV,
ReLU,
MP
CE DICE=0.76
[18] Breast H&E 40x-
20x
Metastasis dec-
tion
399 – Camelyon17 296× 296 – Affine Inception Inception
blocks
CE AUC=0.99
[38] Breast H&E – Metastasis detec-
tion
399 – Camelyon17 296× 296 – Affine Inception Inception
blocks
CE AUC=0.99
[50] Breast H&E 40x Metastasis detec-
tion
399 – Camelyon17 256× 256 – Affine ResNet 101 Residual
blocks
WCE FROC=0.75
[15] Prostate
Kidneys
H&E – Nuclei classif. 8/6 – – – – Rotation Resnet 50 Residual
blocks
CE F1=0.99
[69] Hep2 IF – Cell classif. 28 1457 ICPR2012 224× 224 – – AlexNet 8 CONV,
ReLU,
MP, FC
CE ACC=0.77
[71] Breast IHC 40x Image scoring 172 – Her2 – – AlexNet
Incep-
tion
8/16 CONV,
ReLU,
UP
CE Agreement
Points=382.5
[109] Lung H&E – Cell classif. 257 – TCIA-NLST 40× 40 – – FCN 3 CONV,
ReLU,
MP
CE Kaplan-Meier
curves
[104] Epithelium IHC
H&E
20x Tissue classif. 157/27 – Released 80× 80 – – FCN 5 CONV,
ReLU,
MP
CE ACC=100
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[58] Breast H&E 40x Tumor detection
and segm.
270 – Camelyon16 299× 299 – – Inception 16 CONV,
ReLU,
MP
CE FROC
[67] Breast H&E – Tissue classif. 400 – ICIAR18 512× 512 – Rotations CNN 15/6 CONV,
ReLU,
MP
CE AUC=0.98
[34] Brain H&E 20x Malignant
gliomas grad-
ing
22 7066 TCGA 256× 256 – – CNN 6/12 CONV,
ReLU,
MP
CE ConfMat
[66] Brain Kid-
ney
H&E 40x Morphometric
signatures classif.
2500/
1400
– TCGA-KIRC 100× 100 – Rotation, flip SAE 2 FC MSE+L2 ConfMat
[17] Breast H&E 20x Cancer classif. 646 – – 224× 224 – Affine VGG 16 CONV,
ReLU,
MP,UP
WCE AUC=0.92
[94] Breast H&E 40x Metastatic cancer
detection and
classif.
400 – Camelyon16 256× 256 – Rotations,
flips, crops
GoogleNet27 CONV,
ReLU,
MP, BN
CE AUC=0.93
[40] lung H&E 20X Cancer grading 64 65K MICCAI-CPM17 224× 224 – – ResNet 32 Residual
blocks
CE ACC=0.81
[74] Prostate H&E 40x Gleason grading 270 – TCGA GDC 256× 256 – – CNN
LSTM
– LSTM
units
CE Hazard=206
[43] Brain lung H&E – Lung cancer clas-
sif.
1064 1.1M TCGA-NSCLC 500× 500 CD Rotation,
mirror, color
jitter
CNN 8 CONV,
ReLU,
MP,
LRN,
DO
CE mAP=0.85
[108] Breast H&E Lymph node
segm.
85 – GLaS – – – FCN 50 Residual
blocks
CE Hausdorff=96.9,
DICE=0.86,
F1=0.86
[10] Breast H&E 40x Cancer segm. 270 12M Camelyon16 224× 224 Background
removal
– CNN-
LSTM
10 LSTM
units
CE F1=0.83,
R=0.83,
P=0.81
[95] Cervix H&E 40x Membrane segm. 200 – – 500× 500 – Rotations
flips
VGG 21 CONV,
ReLU,
MP, UP
ADV F1=0.62,
P=0.61,
R=0.64
[72] Colon H&E 20x Tumor segm. 50 50K – 256× 256 – – CNN 10 CONV,
ELU,
MP, FC
CE F1=0.90,
P=0.88,
R=0.92
[46] Colon H&E – Cancer segm. 930 – – 64× 64 – – VGG 16 CONV,
ReLU,
MP, UP
MIL CE F1=0.83
[22] Colon H&E – Survival 180 – – 585× 585 – – CNN 9 CONV,
ReLU,
MP, FC
CE+L2 Hazard=2.08,
CI=0.95,
AUC=0.66
[15] Prostate
Kidneys
H&E – Nuclei classif. 6/8 826/1278– 78× 78 Grayscale
conversion
Affine ResNet 34 Residual
blocks
CE F1=0.82/0.99
[115] Lung
Brain
H&E 20x Survival 1104
485
255
67K
70K
60K
NLST/TCIA 512× 512 Background
removal
– CNN 6 CONV,
ReLU,
MP, FC
Cox
regr.
C-
index=0.7/0.63/0.60
[113] Lung H&E – Survival 450 – NLST 339× 339 – – CNN 6 CONV,
ReLU,
MP, FC
Cox
regr.
C-index=0.63
[110] Lung
Brain
H&E
Omics
– Survival 106/126– NLST 1024 ×
1024
– – CNN 7 CONV,
ReLU,
MP, FC
Cox
regr.
C-
index=0.63/0.64
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[64] Brain H&E
Omics
20x Survival 769 – TCGA 256× 256 SN Mirror, Color
jitter
VGG 19 CONV,
ReLU,
MP, LN,
FC
Cox
regr.
C-index=0.75
[78] Breast H&E 20x Computational
staining
5455 – TCGA 100× 100 Background
removal
Boosting,
color jitter
CNN-
AE
18 CONV,
ReLU,
MP, FC
MSE+CEAUC=0.95
[44] Breast
Colon
H&E 40x SN 25 200 – 1000 ×
1000
– – SSAE – FC MSE DICE=0.76
[111] Breast
Liver
H&E – SN 125 625 – 299× 299 – – InfoGAN – – ADV+R NMI=0.036
[53] Breast H&E – Data augm. 238 – AMIDA2013 24× 24 CD – CNN 6 CONV,
lReLU,
MP, FC
CE Qualitative
[65] Breast H&E – Domain adapt. 73 1552 TUPAC 63× 63 – Color jitter CNN 6 CONV,
ReLU,
MP, BN,
FC
Multi-
loss
CE
F1=0.62
[80] Breast IHC 40x Data synthesis 32 – – 512× 512 – Color jitter,
rotations,
flips
cGAN – CONV,
lReLU,
MP, FC
ADV Experts Fooled
ACC=0.47
[16] Lung None 40x Digital staining – 2838 – 64× 64 PCA – cGAN – CONV,
lReLU,
MP, FC
ADV SSIM=0.39,
MSE=2.44
[26] Breast H&E 40x Stain transfer 400 180K Camelyon16 – Grayscale
conversion
– cGAN 39 CONV
MP
FC UP
ReLU
ADV+R AUC=0.91,
P=0.84,
R=0.85,
SP=0.84
[21] Pancreas H&E,
IF
10x-
20x
Digital staining – 20K – 256× 256 Registration Color jitter,
rotations,
flips
cGAN – CONV,
ReLU,
MP, UP,
FC
ADV+R DICE=0.9,
PSNR=31.5,
SSIM=0.9
[79] Lung H&E – Stain transfer 5 – – 192× 192 – – CNN – CONV,
ReLU,
MP, FC
MSE Qualitative
[90] Bone mar-
row
H&E – Data synthesis 16 – Enjoypath 28× 28 Grayscale
conversion
– VAE – FC Lower
bound
on log-
likelihood
NATS=1398.3
[51] Colon H&E – Feature visualiza-
tion
176 – – 224× 224 – – ResNet 152 Residual
blocks
CE IOU=0.55
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